| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |